Published in Arthritis Rheum on March 01, 2006
Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol (2015) 1.61
Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf (2012) 1.20
Lupus activity in pregnancy. Rheum Dis Clin North Am (2007) 1.18
Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta (2010) 1.08
Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol (2012) 1.01
Conditions causing disability and current pregnancy among US women with chronic physical disabilities. Med Care (2014) 1.01
Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol (2007) 0.96
Lupus and pregnancy: complex yet manageable. Clin Med Res (2006) 0.94
Primary care physicians' perceptions of rates of unintended pregnancy. Contraception (2011) 0.92
Prevalence and risk factors for postpartum depression symptoms among women with disabilities. Matern Child Health J (2015) 0.90
Regulatory T cells protect from autoimmune arthritis during pregnancy. J Autoimmun (2011) 0.90
Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol (2014) 0.86
Managing pregnancy in inflammatory rheumatological diseases. Arthritis Res Ther (2011) 0.86
Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Fertil Res Pract (2015) 0.84
Management of pregnancy in systemic lupus erythematosus. Nat Rev Rheumatol (2012) 0.84
Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol (2011) 0.83
Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am (1994) 0.82
The management of rheumatic diseases in pregnancy. Scand J Rheumatol (2010) 0.82
Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia. Arthritis Care Res (Hoboken) (2012) 0.79
Using hospital discharge data to identify incident pregnancy-associated cancers: a validation study. BMC Pregnancy Childbirth (2013) 0.79
Primary Cesarean Delivery Patterns among Women with Physical, Sensory, or Intellectual Disabilities. Womens Health Issues (2017) 0.79
Cross-sectional analysis of adverse outcomes in 1,029 pregnancies of Afro-Caribbean women in Trinidad with and without systemic lupus erythematosus. Arthritis Res Ther (2007) 0.78
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder. Neurology (2015) 0.76
[Pregnancy and inflammatory rheumatic diseases]. Z Rheumatol (2013) 0.75
Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol (2016) 0.75
Pregnancy Characteristics and Outcomes among Women at Risk for Disability from Health Conditions Identified in Medical Claims. Womens Health Issues (2016) 0.75
Who receives contraception counseling when starting new lupus medications? The potential roles of race, ethnicity, disease activity, and quality of communication. Lupus (2015) 0.75
Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al. Clin Rheumatol (2013) 0.75
Dermatologic conditions in patients of color who are pregnant. Int J Womens Dermatol (2017) 0.75
Time trends in births and cesarean deliveries among women with disabilities. Disabil Health J (2017) 0.75
Systemic lupus erythematosus pregnancies: the Sarawak experience and review of lupus pregnancies in Asia. Rheumatol Int (2010) 0.75
IgA deficiency, autoimmunity & pregnancy: a population-based matched cohort study. J Clin Immunol (2014) 0.75
Ethnic differences in the number of miscarriages, number of children, perceived family support and the impact of the disease on daily living in patients with systemic lupus erythematosus. Clin Rheumatol (2013) 0.75
Reduced disability and mortality among aging runners: a 21-year longitudinal study. Arch Intern Med (2008) 3.66
Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med (2005) 2.98
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol (2009) 2.39
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med (2012) 2.19
Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development. Arthritis Res Ther (2004) 2.07
Early and extensive erosiveness in peripheral joints predicts atlantoaxial subluxations in patients with rheumatoid arthritis. Arthritis Rheum (2003) 1.62
Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J Rheumatol (2009) 1.58
Factors associated with patients who leave acute-care hospitals against medical advice. Am J Public Health (2007) 1.56
Functional disability in rheumatoid arthritis patients compared with a community population in Finland. Arthritis Rheum (2003) 1.47
Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory. Arthritis Res Ther (2011) 1.44
Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm (2008) 1.42
Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum (2010) 1.42
Lifestyle risk factors predict disability and death in healthy aging adults. Am J Med (2012) 1.27
The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res (Hoboken) (2011) 1.22
Big data and clinicians: a review on the state of the science. JMIR Med Inform (2014) 1.17
Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol (2004) 1.17
The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration. J Rheumatol (2011) 1.14
Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum (2013) 1.12
Muscle strength, mass, and quality in older men and women with knee osteoarthritis. Arthritis Care Res (Hoboken) (2012) 1.10
Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank. Arch Phys Med Rehabil (2013) 1.09
The components of action planning and their associations with behavior and health outcomes. Chronic Illn (2013) 1.07
Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol (2009) 1.05
Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis (2013) 1.04
Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy. Neurology (2003) 0.99
Items, Instruments, Crosswalks, and PROMIS. J Rheumatol (2009) 0.98
Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009. Arthritis Res Ther (2013) 0.95
Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology (2007) 0.95
A randomized, controlled trial of interferon-beta-1a (Avonex(R)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]. Arthritis Res Ther (2003) 0.94
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect (2008) 0.94
Chronic kidney disease in gout in a managed care setting. BMC Nephrol (2011) 0.93
Development and assessment of floor and ceiling items for the PROMIS physical function item bank. Arthritis Res Ther (2013) 0.91
Exercise behavior of ultramarathon runners: baseline findings from the ULTRA study. J Strength Cond Res (2013) 0.90
Dutch translation and cross-cultural adaptation of the PROMIS® physical function item bank and cognitive pre-test in Dutch arthritis patients. Arthritis Res Ther (2012) 0.88
Systemic lupus erythematosus, rheumatoid arthritis, and postarthroplasty mortality: a cross-sectional analysis from the nationwide inpatient sample. J Rheumatol (2010) 0.87
Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings. Curr Med Res Opin (2011) 0.84
Extending the floor and the ceiling for assessment of physical function. Arthritis Rheumatol (2014) 0.83
Sleep-disordered breathing among women with fibromyalgia syndrome. J Clin Rheumatol (2006) 0.82
An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis. J Rheumatol (2011) 0.81
What constitutes progress in assessing patient outcomes? J Clin Epidemiol (2009) 0.81
Relative performance of commonly used physical function questionnaires in rheumatoid arthritis and a patient-reported outcomes measurement information system computerized adaptive test. Arthritis Rheumatol (2014) 0.80
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. Arthritis Res Ther (2013) 0.79
Body mass index and its correlates in 1,212 ultramarathon runners: baseline findings from the ULTRA study. J Phys Act Health (2013) 0.78
Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.77
Rheumatoid arthritis: radiographic progression is getting milder. J Rheumatol (2005) 0.77
Unregistered trials are unethical. PLoS Med (2005) 0.75
Gout and the heart. Rheum Dis Clin North Am (2014) 0.75
National databases and rheumatology research II: the National Health and Nutrition Examination Surveys. Rheum Dis Clin North Am (2004) 0.75
Filipino gout: a review. Arthritis Care Res (Hoboken) (2014) 0.75
A short tutorial on item response theory in rheumatology. Clin Exp Rheumatol (2014) 0.75
Pegloticase and the patient with treatment-failure gout. Expert Rev Clin Pharmacol (2012) 0.75
Systemic sclerosis 2011. Int J Rheumatol (2012) 0.75
Vascular disease in systemic sclerosis. Int J Rheumatol (2010) 0.75